Heike Schneider Selected Research

Heike Schneider Research Topics

Disease

6	Neoplasms (Cancer) 04/2024 - 10/2003
4	Inflammation (Inflammations) 06/2023 - 01/2014
3	Brain Neoplasms (Brain Tumor) 01/2024 - 01/2019
3	Infections 01/2021 - 06/2013
2	Seizures (Absence Seizure) 01/2023 - 01/2019
2	Dementia (Dementias) 04/2022 - 01/2020
2	Tachycardia (Tachyarrhythmias) 08/2020 - 03/2011
2	Ventricular Tachycardia 01/2020 - 11/2007
2	Disease Progression 01/2017 - 01/2014
2	Body Weight (Weight, Body) 06/2016 - 09/2009
2	Calculi (Calculus) 04/2015 - 01/2012
1	Supratentorial Neoplasms 01/2024
1	COVID-19 11/2023
1	Lymphoma (Lymphomas) 10/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2023
1	Abdominal Aortic Aneurysm 06/2023
1	Fibrosis (Cirrhosis) 06/2023
1	Cysts 01/2023
1	Cognitive Dysfunction 04/2022
1	Congenital Heart Defects (Congenital Heart Defect) 08/2020
1	Urinary Tract Infections (Urinary Tract Infection) 01/2020
1	Bacteriuria 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Endocarditis 09/2019
1	Rupture 09/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Glioma (Gliomas) 01/2019
1	Accessory Atrioventricular Bundle 06/2016
1	Portal Hypertension 12/2014
1	Severe Acute Respiratory Syndrome 10/2014
1	Coronavirus Infections 10/2014
1	Colitis-Associated Neoplasms 07/2014
1	Ulcerative Colitis 07/2014
1	Colitis 07/2014
1	Sepsis (Septicemia) 07/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2014
1	Arteriovenous Malformations (Arteriovenous Malformation) 05/2014
1	Glioblastoma (Glioblastoma Multiforme) 10/2013
1	Melanoma (Melanoma, Malignant) 04/2012
1	End Stage Liver Disease 01/2012
1	Renal Insufficiency (Renal Failure) 01/2012
1	Mastocytoma 04/2011

Drug/Important Bio-Agent (IBA)

2	Uric Acid (Urate)IBA 04/2015 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 10/2014 - 04/2012
2	CytokinesIBA 01/2014 - 04/2012
1	salicylhydroxamic acid (SHAM)IBA 01/2024
1	Retinaldehyde (Retinal)IBA 11/2023
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2023
1	Programmed Cell Death 1 ReceptorIBA 10/2023
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 10/2023
1	Coenzyme A (CoA)IBA 10/2023
1	Immunoglobulin G (IgG)IBA 06/2023
1	N- phenylacetoaminomethylene- DL- p- nitrophenylalanine (A 101)IBA 06/2023
1	Contrast MediaIBA 01/2023
1	Ginkgo ExtractIBA 04/2022
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2020
1	ProcalcitoninIBA 01/2020
1	Donepezil (Aricept)FDA LinkGeneric 01/2020
1	Vitamin D FDA LinkGeneric 01/2019
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2017
1	IntegrinsIBA 10/2015
1	Calcium OxalateIBA 04/2015
1	Thrombin FDA Link 11/2014
1	AzoxymethaneIBA 07/2014
1	NucleotidesIBA 07/2014
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 07/2014
1	LipopolysaccharidesIBA 07/2014
1	Dextrans (Dextran)FDA Link 07/2014
1	CopperIBA 07/2014
1	Transcription Factors (Transcription Factor)IBA 07/2014
1	ChemokinesIBA 01/2014
1	PlasticsIBA 10/2013
1	Cathepsin LIBA 06/2013
1	Peptide Hydrolases (Proteases)FDA Link 06/2013
1	CD13 Antigens (Alanine Aminopeptidase)IBA 04/2012
1	CreatinineIBA 01/2012
1	Alanine Transaminase (SGPT)IBA 01/2012
1	Nerve Growth Factor (NGF)IBA 04/2011
1	TropomyosinIBA 04/2011
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 04/2011
1	Imatinib Mesylate (Gleevec)FDA Link 04/2011
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 04/2011
1	Tyrosine Kinase InhibitorsIBA 04/2011
1	Phosphotransferases (Kinase)IBA 04/2011

Therapy/Procedure

7	Transcranial Magnetic Stimulation 01/2024 - 10/2013
3	Catheters 01/2021 - 03/2011
3	Catheter Ablation 08/2020 - 11/2007
2	Stents 09/2019 - 12/2014
2	Transjugular Intrahepatic Portasystemic Shunt 12/2014 - 01/2012
1	Conservative Treatment 04/2024
1	Electrodes (Electrode) 08/2020
1	Defibrillators (Defibrillator) 01/2020
1	Surgical Instruments (Clip) 09/2019
1	Punctures 07/2014
1	Ligation 07/2014
1	Intraperitoneal Injections 07/2014
1	Drug Tapering 06/2014
1	Therapeutics 01/2014